DotCom News
Recent Newswire Stories from PRnetwire and eNewsChannels.com
Edited by Carly Zander, associate news editor
'LET'S SIMPLIFY THE CANADIAN DRUG RE-IMPORTATION ISSUE ONCE AND FOR ALL,' SAYS OWNER OF CANADIAN PHARMACY
WINNIPEG, MANITOBA - Nov. 10, 2003 /Send2Press Newswire/ -- As the owner
of CanadianOnlineRX.com it only makes sense for the millions of
Americans on fixed incomes to buy medications from Canada, says company
president Robert Becker.
"We can save Americans up to 85% on their prescriptions. The Canadian
government implements costing control over the large pharmaceutical
manufacturers (Big Pharma). This coupled with the exchange rate of the
Canadian dollar makes medication much more affordable in Canada. This is
extremely alluring to American seniors, those who are uninsured,
underinsured or simply can t afford the much higher U.S. cost for
medicine. In fact many American civic, county and state governments with
budgetary woes are seriously looking at buying medication from Canada."
"Regulated certified licensed Canadian pharmacies guarantee high quality
and safe products more so than any other country in the world. We say
this because most of the medications shipped to the U.S. are
manufactured in the U.S. and are the same medications sold by American
pharmacies. You don t see Canadians dropping dead from these same
medications that are re-imported to the U.S. Canadian pharmacies and
pharmacists practice the highest of safety standards and must adhere to
extensive safety and ethical regulations or their licenses would be
revoked."
"There has never been one documented incident of an American
that has suffered any form of injury by medication re-imported from
Canada. Yet Big Pharma and political opponents of drug re-importation
from Canada continue to fear monger the issue of safety. Big pharma is
actually creating safety issues by limiting Americans access to their
products with their price gouging."
Contines Becker, "The only reason the Canadian online pharmacy industry
exists is because the large drug manufactures (Big Pharma) are price
gouging the American public. They cite Research and Development to
justify their unscrupulous high prices. Yet they only spend 11% to 15%
of their revenues on R&D and up to 35% on advertising. Does Big Pharma
really need to spend this much on advertising while the American public
is forced to pay for drug R&D for the rest of the world?"
"Canadian cross-border sales of safe and affordable medication barely
make up 1% of Big Pharma s revenues. This is not what scares or
motivates Big Pharma to shut down drug re-importation from Canada. We
are just a drop in the bucket to them. Big Pharma is afraid the American
public will stand up and take their politicians to task. From what I can
see, Big Pharma needs to be afraid."
In an article published today in the Financial Times, "Canada yesterday
introduced a bill to allow the export of cheap generic drugs to poor
countries stricken by epidemics such as AIDS, malaria and tuberculosis.
It is the first country to introduce such legislation since a World
Health Organization agreement in August paved the way for such exports.
This is one of the most important steps Canada can take to advance
global health and human rights and we hope to see other G8
[industrialized] countries following suit," said Bill Graham, foreign
affairs minister. The proposals were "broad, flexible and faithful to
what WTO members have spent so long negotiating," said Pierre Pettigrew,
international trade minister.
"Ethically," says Becker, "I see no difference between an American
senior or a citizen from a third world country being denied access to
safe, affordable and often times life sustaining medication because of
unscrupulous corporate greed and practices or political positioning."
Canadian online pharmacies are not the cause nor the cure for the
disproportionate pricing for medication between the U.S. and other
industrialized nations. This is an issue that has to be addressed on
Capitol Hill and at the voting booths of America. And without the
financial influence of Big Pharma.
Until Americans can find cost parity at their local pharmacies, they
will look north for more humane medication costs. Until that happens and
should Big Pharma and the political opponents to Canadian drug
re-importation shut down the border, Americans will be forced to go else
where to find affordable medication. The only problem then is that
Americans will not be buying safe quality medication that has been
manufactured in the U.S. and to both U.S. and Canadian health standards.
This may pose the greatest safety risk of all.
CanadianOnlineRX.com, 1205 Richard Avenue, Winnipeg, Manitoba, Canada
R3E 3H3. Ph: (877) 337-8470
Organization Website:
www.CanadianOnlineRX.com
Source of News:
CanadianOnlineRX.com
Canada Business Newswire
/
DotCom Newswire
> Read original news release in raw text format
> Read original news release in PDF format
> More DotCom News
>
More Canada Business News
> Other Recent News Stories
FOR INFORMATION ABOUT THE COMPANY OR ORGANIZATION(S) MENTIONED IN THE ABOVE NEWS ITEM, PLEASE CONTACT THE COMPANY DIRECTLY. SEND2PRESS/NEOTROPE IS NOT A REPRESENTATIVE OF, AND DOES NOT OFFER FURTHER INFORMATION ABOUT, ANY COMPANY MENTIONED IN THE ABOVE NEWS ITEM.
DISCLAIMER: the above news article is believed accurate but not guaranteed, and is based on news supplied by the company or organization mentioned and/or quoted in the story. Neotrope/Send2Press makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news item are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope/Send2Press. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. Reproduction of this news article in any form requires written authorization. You may freely link to this article. PRnetwire (www.PRnetwire.com) is a unit of Neotrope, and is not related to PR Newswire®. Keyword marketing technology by DotComMojo, a unit of Neotrope.
NEWSWIRE TERMS OF USE
|